SIU 2020 Abstract Listing



Standard ePosterAdrenalsSP-01.01 A 16 Year Review of Management of Incidental Adrenal Masses: Should We Remove Based on Size Alone?Melissa Gabriel, United KingdomSP-01.02Laparoscopic Adrenalectomy for Malignant Tumors: A Retrospective Analysis of Kyushu University HospitalKeisuke Monji, JapanSP-01.03Laparoscopic Adrenalectomy: Outcomes of Enhanced Recovery Pathways at our Regional Cancer CentreFlora Langman, United KingdomBasic Science - Benign Diseases SP-02.01Comparative Analysis of Gut Microbiome Composition Between Men with Peyronie’s Disease and a Matched Cohort: Is there a Difference?Mohamad Osman, United StatesSP-02.02Congenital Malformations of the Genito-Urinary Tract Associated to Isodicentric Yq ChromosomeNouha Bouayed Abdelmoula, TunisiaSP-02.05Nerve Growth Factor Precursor (proNGF) Exerts Different Biological Actions on Urothelial and Smooth Muscle Cells of Rodents BladdersAbubakr Mossa, CanadaBladder Cancer SP-03.03Global BCG Shortage Affects Bladder Cancer TreatmentMichael Harvey, AustraliaSP-03.04Investigating the Association between the Urinary Microbiome and Bladder Cancer: An Exploratory StudyUmar Iqbal, United StatesSP-03.08Optimizing Sequence of Therapy and Radiation Delivery When Combined with PD-L1 Immune-Checkpoint Inhibition in Bladder CancerC?me Tholomier, CanadaSP-03.10Review of Bacillus Calmette-Guerin (BCG) Tolerability and Complications of Intravesical Therapy for Non-Muscle Invasive Bladder Cancer (NMIBC) Over a 4 Year PeriodVenetia Hoe, AustraliaSP-03.13The Role of Perpheric Inflammatory Markers in the Prognosis of Non-Muscle Invasive Bladder CancerRoberto Martínez, SpainSP-03.15Anaerobic Threshold Correlated to Length of Hospital Stay and Complication Rate for Radical Cystectomy PatientsMriganka Mani Sinha, United KingdomSP-03.16Assessing the Safety of Follow-Up After Induction BCG Using Urine Cytology and Flexible CystoscopyLisa Bibby, United KingdomSP-03.17Comparing Costs of Radical Versus Partial Cystectomy for Patients Diagnosed with Localized Muscle-Invasive Bladder Cancer: Understanding the Value of Surgical CareAditya Srinivasan, United StatesSP-03.19Comparison Low Pressure to Standard Pressure Robotic Assisted Radical Cystectomy: A Pilot studyVishwanath Hanchanale, United KingdomSP-03.20Comparison of Open Radical Cystectomy versus Robotic assisted Radical Cystectomy: Our experience at Tertiary Care CentreAvinash Ranganagouda Odugoudar, United KingdomSP-03.21Complete Urinary Tract Exenteration (CUTE) for Invasive Bladder Urothelial Carcinoma in ESRD Patient on HemodialysisMagdy El-Bahnasawy, Saudi ArabiaSP-03.23COVID-19 and Bladder Cancer: Are Social and Clinical Restrictions Presenting Barriers to Patients Requiring Transurethral Resection of Bladder Tumour (TURBT)?Dominic Bagguley, AustraliaSP-03.24Diagnostic and Surveillance Cystoscopy for Bladder Cancer – Pushing Boundaries During COVID-19Dominic Bagguley, AustraliaSP-03.26Enhanced Recovery After Surgery for Robotic-Assisted Laparoscopic Radical Cystectomy: A Single-Center ExperienceFu Ho Victor Cheung, Hong KongSP-03.27Geographic Distribution of Racial Differences in Bladder Cancer Mortality in the United States: A Nationwide Population-Based StudyAriza Martinez, United StatesSP-03.28Immunotherapy in Advanced Urothelial Cancer: Initial ExperienceLorena García García, SpainSP-03.29Is Re-Resection TUR Always Needed in the Management of Patients with High-Risk Non-Muscle-Invasive Bladder Cancer (TaG3/T1 with or without CIS) Treated with Bacillus Calmette-Guerin?Kenneth Hiew, United KingdomSP-03.32Oncological Outcomes of Contemporary Series of Robot-Assisted versus Open Radical Cystectomy at 10 Years Follow upMuhammad Waqar, United KingdomSP-03.33Oncological, Sexual, and Urinary Outcomes of Organ-Sparing Cystectomy versus Standard Radical Cystectomy: A Systematic Review and Meta-AnalysisRaghav Shaunak, United KingdomSP-03.34Osmotic Cytolytic Effects of Water on Cell Counts - Implication for Clinical Use of Water Irrigation to Reduce NMIBC RecurrenceRuchira Nandurkar, AustraliaSP-03.35Outpatient Transurethral Laser Ablation for Urothelial Cancer – A Safe Alternative to TURBT in the Era of COVID-19James Aljoe, United KingdomSP-03.36Perioperative and Oncologic Outcomes of Robot-Assisted Radical Cystectomy in North American versus European Institutes Utilizing the International Robotic Cystectomy ConsortiumUmar Iqbal, United StatesSP-03.39Prostate Specific Membrane Antigen (PSMA) in Urothelial Cell Carcinoma (UCC): A Systematic Review of the LiteratureArsalan Tariq, AustraliaSP-03.40Proximity to Oil Refineries and Risk of Bladder Cancer: A Population-Based AnalysisAditya Srinivasan, United StatesSP-03.41Radical Cystectomies – Too Many Doing Too Few Reflects in Length of StayNuno Dias, PortugalSP-03.42Radical Cystectomy in Elderly Patients: Postoperative Complications and Oncological OutcomesAlberto del Cristo Artiles Medina, SpainSP-03.43Relapse Rates, Patterns, and Survival After Robot-Assisted Radical: Results from the International Robotic Cystectomy ConsortiumUmar Iqbal, United StatesSP-03.44Robotic Cystectomy Histopathology Outcomes in Patients Who Have ‘Failed’ BCGEdward Hart, United KingdomSP-03.45Role of the Preoperative Magnetic Resonance Imaging in Classifying Non-Muscle and Muscle Invasive Bladder CancerTeak Jun Shin, South KoreaSP-03.48Trends of Neobladder Formation in AustraliaElena Galiabovitch, AustraliaSP-03.49Urine Cytology: Why Don't Requesting Clinicians Follow Guidelines?Jake Tempo, AustraliaSP-03.51Variants of Urotelial Bladder Cancer. A New Indication for Early Cystectomy?Bego?a Ballesta Martínez, SpainBPO/LUTS SP-04.01A Novel Method for GreenLightTM MoXy? Laser Fiber Irrigation System to Improve Performance and Durability: A New Standard of Care?Kyle W. Law, CanadaSP-04.02A Pilot Study to Assess Efficacy and Safety of Methoxyflurane for Pain Control During Convective Thermal Therapy Using Rezūm System in System in Benign Prostatic Hyperplasia (BPH)Dean Elterman, CanadaSP-04.03A Prospective Study on Safety and Efficacy of Minirin Melt in Elderly Chinese Patients with NocturiaYiu Chung Lam, Hong KongSP-04.04A Retrospective Comparison of 1470 nm Diode Laser Enucleation and Bipolar Transurethral Resection of the Prostate for the Treatment of Benign Prostatic HyperplasiaSina Hassan Beygi Monfared, United StatesSP-04.05An Assessment of the Impact of Bipolar Technology on Transurethral Resection of the Prostate (TURP) Outcomes: Results of Indirect Comparisons from a Cochrane ReviewCameron E. Alexander, United KingdomSP-04.06Analysis of Present Status for Surgery of Benign Prostatic Hyperplasia in Korea Using Nationwide Healthcare System DataByeong Jo Jeon, South KoreaSP-04.08Assessing the Learning Curve of Robotic Aquablation of the Prostate: Surgical Outcomes from Two International CentersAlbert El Hajj, LebanonSP-04.09B3 Agonists or Anticholinergics in the Treatment of the Lower Urinary Tract Symptoms in Patients with Multiple Sclerosis: A Randomized StudyIoannis Glykas, GreeceSP-04.10Changing Trends in Patient Profile and Outcomes of Transurethral Resection of Prostate: Single Center Experience of Transition from Monopolar to Bipolar Transurethral Resection of ProstateSwaroop S, IndiaSP-04.11Clinical Management Issues and Causes of Death in Patients Dying After Endoscopic Prostate SurgeryElena Galiabovitch, AustraliaSP-04.12Comparison of HoLEP TechniquesBranimir Penev, United KingdomSP-04.13Economic Evaluation of 1470 nm Diode Laser Enucleation vs. Bipolar Transurethral Resection of the ProstateAnnaliese Ionson, United StatesSP-04.14En Bloc versus Incisional Technique for Holmium Laser Enucleation of Prostate (HoLEP): A Comparison of Operative EfficiencyKamran Bhopal, United KingdomSP-04.15Evolving Practices in the Treatment of Refractory Overactive BladderAoife McVey, AustraliaSP-04.16Foreplay Incontinence, Climacturia, and Stress Incontinence Treated with Mini-Jupette SlingsEdward Choi, United StatesSP-04.17Global GreenLight Group: Largest International GreenLight Experience for Benign Prostatic HyperplasiaKyle W. Law, CanadaSP-04.19Holmium Laser Enucleation of the Prostate (HoLEP): A Pilot Study of Three-Lobe versus En Bloc EnucleationElshadaie Solomon, United KingdomSP-04.21Impact of Transurethral Resection of the Prostate (TURP) Technology on Post-Operative Urethral Stricture Outcomes: Extended Analysis from a Cochrane ReviewCameron E Alexander, United KingdomSP-04.22Largest Canadian Cohort of Rezūm Therapy for Large Volume Benign Prostatic Hyperplasia (BPH)Dean Elterman, CanadaSP-04.24Mirabegron vs. Placebo Add-On Therapy in Men with Overactive Bladder Symptoms Receiving Tamsulosin for Underlying Benign Prostatic Hyperplasia: A Safety Analysis from the Plus StudySender Herschorn, CanadaSP-04.27Perioperative Outcome after Robotic-Assisted Simple Prostatectomy on Lower Urinary Tract Symptoms of Prostatic OriginChe Hsueh Yang, TaiwanSP-04.28Photoselective Vaporization of the Prostate with Green Light XPS 180-Watt Laser for Men with Benign Prostatic Hyperplasia: A Case Series from 2015 to 2019Mario Gonzalez, Costa RicaSP-04.30Relationship between Serum Dihydrotestosterone and Benign Prostatic ObstructionKhalifa Abdulsalam, NigeriaSP-04.31Review of Bladder Outflow Obstruction Treatment (ReBOOT) in the Context of Novel Procedures and New Antiplatelet and Anticoagulant Therapy.Lisa Bibby, United KingdomSP-04.32The Contino? Urethral Insert in the Treatment of Male Stress Urinary IncontinenceDean Elterman, CanadaSP-04.33The Effect of Intravesical Prostatic Protrusion on Urinary Outflow ObstructionHira Bumbia, PakistanSP-04.36The Impact of Diet, Fluid Intake, Caffeine, Alcohol and Tobacco on Lower Urinary Tract SymptomsAlaa Ali, IraqSP-04.37The Safe Implementation of Early Removal of the Catheter Post-Bipolar TURP: Experience of a Multi-Centre District General Hospital in the United KingdomAngus Bruce, United KingdomSP-04.38Transfusion Rates with Focal Bladder Neck Cautery Following AquablationDean Elterman, CanadaSP-04.39Transition from Day Theatre to Ambulatory Setting for Prostatic Urethral Lift in Fife, UKPetros Tsafrakidis, United KingdomSP-04.40TURP Post UroLift: Symptomatic Management or Inevitable Re-intervention?Sachin Perera, AustraliaSP-04.41Urodynamic Findings in Men with Persistent Lower Urinary Tract Symptoms Post Transurethral Prostate SurgeryAoife McVey, AustraliaSP-04.42VALOUR: Evaluation of a Novel Visual Analogue Uroflowmetry Score (VAUS) to Support Shared Decision-Making for Men with Lower Urinary Tract Symptoms and their Primary Care PhysiciansShu Hui Neo, SingaporeFemale UrologySP-05.01Analysis of Prescribing Trends in Female Overactive Bladder based on a Large-scale Claims Database in JapanSachiko Kasamo, JapanSP-05.02Clinical and Videourodynamic Study Characteristics in Female Primary Bladder Neck Obstruction and Outcomes of Bladder Neck ResectionSidhartha Kalra, IndiaSP-05.03Female Urethral Stricture Disease: Consider a More Modern ApproachZulfadhly Murtadha Afiq Zainal Bahren, New ZealandSP-05.04Is It Safe and Effective to Perform Dorsal Onlay Buccal Mucosal Graft Urethroplasty for Either Intrinsic or Extrinsic Recalcitrant Female Bladder Outlet Obstruction?Alvaro Saavedra, ChileSP-05.05Onabotulinumtoxina Injection to the External Urethral Sphincter for Voiding Dysfunction in Females: A Tertiary Centre ExperienceMehwash Nadeem, United KingdomSP-05.06Pelvic Floor Electrical Stimulation as a Treatment for Stress Urinary Incontinence: Is It Effective?Emny Rochell Bobadilla Romero, SpainSP-05.07Prospective Data as a Weapon against the Extinction of Mid-Urethral Slings (MUS): A Single-Center Pilot StudyKristel Ferong, BelgiumSP-05.08Radiological Characterization of Synthetic Mesh in Female Urological Procedures: A Review of the LiteratureAriza Martinez, United StatesSP-05.09Real-Life Outcomes after Artificial Urinary Sphincter Explantation in Women Suffering from Severe Stress Incontinence.Thibault Tricard, FranceSP-05.10Rectocele and Voiding Dysfunction: Experiences in UrologyRomy Mondschein, AustraliaSP-05.13Stimulation Alone Versus Stimulation Associated with Perineal Reeducation for the Treatment of Idiopathic Overactive Bladder in Menopausal WomenSkander Zouari, TunisiaSP-05.14Surgical Management of Youssef’s Syndrome: A Case Report and Literature ReviewRedha Kettache, AlgeriaSP-05.15Surgical Outcomes in Female Urethral DiverticulumAndrew McAdam, United KingdomSP-05.16The Role of CT-Guided Pudendal Nerve Block in the Pudendal Neuralgia (PN) DiagnosisAlberto del Cristo Artiles Medina, SpainHistory of Medicine SP-06.01Francois de la Peyronie: The Man Behind the Eponymous DiseaseMatthew Oxenham, United KingdomSP-06.02Hydroceles: Major Landmarks in Management Through HistoryMohammed Quraishi, United KingdomSP-06.03Too Often Too Soon Too Late: BPH Surgery Through the AgesNimlan Shanmugathas, United KingdomInfections and Inflammatory Diseases SP-07.02Antimicrobial Prophylaxis for Subjects Undergoing TRPB: A Network Meta-Analysis on Appropriate Dosing Regimen of Fosfomycin TrometamolMichaela Tutone, ItalySP-07.03Clinical Characteristics of Urosepsis Caused by Ureteral CalculiKuniyasu Muraoka, JapanSP-07.04Clinical Implications of SURF-data (SUsceptibility and Resistance of Uropathogens to Fosfomycin in Comparison with Other Antimicrobial Agents) on Empirical Treatment of Uncomplicated Urinary Tract Infections in WomenTommaso Cai, NorwaySP-07.05Comparison Between Transperitoneal and Retroperitoneal Approach for the Treatment of Xanthogranulomatous Pyelonephritis. Is There Any Difference?Fred Alain Montelongo-Rodríguez, MexicoSP-07.06Comparison of Targeted and Empirical Antibiotics Prophylaxis in Preventing Infectious Complications After Transrectal Prostatic Needle Biopsy at a Nigerian Teaching HospitalTaofiq Olayinka Mohammed, NigeriaSP-07.07Decreased Inflammatory Response of Urothelial and Smooth Muscle Cells to Lipopolysaccharides by P75NTR AntagonismBenjamin Desormeau, CanadaSP-07.08Fournier’s Gangrene: A Retrospective Review of Management Outcomes and the Seasons of PresentationIkenna I. Nnabugwu, NigeriaSP-07.09Fournier's Gangrene: Our ExperienceGil Falc?o, PortugalSP-07.10High Survival Rate with Fournier's Gangrene: The Ibadan ExperienceOlukayode Abayomi, NigeriaSP-07.11Improved Outcomes from Optimised Preoperative Urine Culture GuidelinesElliot Anderson, AustraliaSP-07.12Intra Renal Antifungal Treatment for Persistent Bilateral Renal Aspergillus Terreus InfectionVaibhav Vishal, IndiaSP-07.13Is Immediate Preoperative Blood Glucose or Hemoglobin A1c a Risk Factor for Infection Following Penile Prosthesis Placement? A Systematic Review of LiteratureLinda Huynh, United StatesSP-07.15Management of Urological Emergencies of Scrotum During Covid-19 Pandemic – A Prospective StudyMustafa Rashid, United KingdomSP-07.16Predictive Factors Associated to Intensive Care Unit Admission and Mortality in Patients with Emphysematous Pyelonephritis: A 5-Year Experience in a Tertiary Care CenterJosé Iván Robles-Torres, MexicoSP-07.17Psychological Health Among Urology Providers during the COVID-19 Pandemic: A Cross-Sectional Study at a Tertiary Academic CentreYi Quan Tan, SingaporeSP-07.18Review of Urinary Schistosomiasis and its Sequelae in a Tertiary Hospital of North Western Nigeria.Abubakar Sadiq Muhammad, NigeriaSP-07.19Risk of COVID-19 Transmission During Urological Surgical Procedures: A Systematic ReviewJen Hoogenes, CanadaSP-07.20SURF (SUsceptibility and Resistance of uropathogens to Fosfomycin] in Comparison with Other Antimicrobial Agents: An International Microbiological Surveillance StudyTruls E. Bjerklund Johansen, NorwaySP-07.21The Periurethral Abscess: An Unusual Emergency Department PresentationArsalan Tariq, AustraliaSP-07.22The Role of Double-J Stent Culture in Predicting Urinary Tract Infection in Patients Undergoing Endoscopic Urinary System Stone SurgeryFerhat Keser, TurkeySP-07.23Urology Theatre Cancellations Due to Positive Urine Dipstick/Asymptomatic BacteriuriaJosie Colemeadow, United KingdomSP-07.24Utility of Videourodynamics, Imaging, and Cystoscopy in Voiding Dysfunction and Recurrent Urinary Tract Infections: Should we throw in the kitchen sink?Aoife McVey, AustraliaSP-07.25Vitamin D Deficiency May Contribute to Increased Risk of Urinary Tract Infection: A Systematic Review and Meta-AnalysisNiwanda Yogiswara, IndonesiaSP-07.26Which Microbiological Specimens Should Be Obtained in Patients Undergoing Ureteral Stenting for Acute Obstructive Pyelonephritis?Nuno Dias, PortugalInfertilitySP-08.03Emotional Health and Its Impact on Assisted Reproductive Technology Outcomes: A Systematic Review and Meta-AnalysisGrace Peaston, United KingdomSP-08.04Female Chromosomal Findings Prior Intracytoplasmic Sperm Injection TreatmentNouha Bouayed Abdelmoula, TunisiaSP-08.05Infertility Phenotype as a Result of Cytogenetic Abnormalities Involving Chromosome 2: From Teratozoospermia to AzoospermiaNouha Bouayed Abdelmoula, TunisiaSP-08.06Post-Market Safety and Efficacy Profile of Subcutaneous Testosterone Enanthate-AutoinjectorPerry Xu, United StatesSP-08.07Recurrent Pregnancy Losses and Chromosomal Imbalances: Genetic Counselling and Preimplantation Genetic Diagnosis Indication Using Next-Generation Sequencing TechnologyNouha Bouayed Abdelmoula, TunisiaSP-08.08Review of Male infertility in a Tertiary Hospital of North Western NigeriaAbubakar Sadiq Muhammad, NigeriaSP-08.09Small Supernumerary Marker Chromosomes and Male Infertility: What Are the Chances of Preimplantation Genetic Testing?Nouha Bouayed Abdelmoula, TunisiaSP-08.10Synbiotic Administration in Idiopathic Male Infertility Enhances Sperm Quality and Chromatin Status: A Triple-Blinded Randomized Clinical TrialBehzad Abbasi, IranSP-08.11Technical Support of Y Chromosome Microdeletion Testing in Male InfertilityNouha Bouayed Abdelmoula, TunisiaKidney and Ureter, Benign Diseases SP-09.02A Report on The Outcome Following Mini Percutaneous Nephrolithotomy (MPCNL) for Renal Calculi: Our Initial Experience and Challenges in University Malaya Medical Centre (UMMC), Malaysia.See Boon Keong, MalaysiaSP-09.04Association Between Time to SWL and Stone Free Rate in Ureteral StonesSatoshi Washino, JapanSP-09.05Congenital Renal Anomalies Diagnosed in Adulthood: Experience from a Sub-Saharan African CohortRotimi David, NigeriaSP-09.06Day-Case (Catheter Less and Drain Less) Robotic Assisted Pyeloplasty in Adults – Single Centre Experience at a UK Teaching HospitalVinodh Murali, United KingdomSP-09.07Development and Validation of a Nomogram for Chronic Kidney Disease Following Robot-Assisted Radical CystectomyUmar Iqbal, United StatesSP-09.08Epitheliod Renal Angiomyolipoma With Renal Vein Tumor ThrombusMagdy El-Bahnasawy, Saudi ArabiaSP-09.10Predictive Factors for Complications After an Ultrasound-Guided Renal BiopsyEmny Rochell Bobadilla Romero, SpainSP-09.11Renal Parenchymal Thickness as a Predictor of Bleeding After Percutaneous NephrolithotomyEmny Rochell Bobadilla Romero, SpainSP-09.12Ureteroileal Strictures. Can Endoscopic Treatment Prevent the Need for Ureteric Re-Implantation?Xuan Rui Sean Ong, AustraliaSP-09.13Urosepsis Post Emergency Ureteric Stent Insertion: Can We Predict Intensive Care Admission?Xuan Rui Sean Ong, AustraliaKidney and Ureteral Cancer SP-10.02Can Checkpoint Inhibitor Immune-Related Adverse Events be a Prognosis Factor in Urothelial Cancer?Gil Falc?o, PortugalSP-10.03IGF2BP Proteins Modulate Metastasis and Tumorigenesis of Renal Cell Cancer by Regulating S1PR3 mRNA StabilityYufan Ying, ChinaSP-10.05Alpha Fetoprotein and Vitamin B12 as Diagnostic and Prognostic Markers for Renal Tumours: A Case of a Giant Hepatoid Renal Cell CarcinomaNikolaos Kostakopoulos, United KingdomSP-10.06Analysis of Treatment and Outcomes of GU Sarcoma Patients Evaluated at Norris Comprehensive Cancer CenterAdam Kolawa, United StatesSP-10.08Comparison of Four Transdiaphragmatic Approaches to Remove Cavoatrial Tumor ThrombiMazen Jundi, CanadaSP-10.09Effect of Cytoreductive Nephrectomy According to First-line Tyrosine Kinase Inhibitor Treatment in Synchronous Metastatic Clear Cell Renal Cell Carcinoma: Sunitinib Versus Pazopanib, a Multicenter StudyTeak Jun Shin, South KoreaSP-10.10Factors Affecting eGFR Preservation Post Radical NephrectomyJohn El-Khoury, AustraliaSP-10.11Impact of Predictive Factors Focused on Complete Blood Count and Serum Creatinine Level in Patients with Upper Urinary Tract Urothelial Carcinoma Undergoing Radical NephroureterectomySkander Zouari, TunisiaSP-10.13Non-Closure Technique for Robotic Partial Nephrectomy (RPN) for Hilar TumoursKermith Ayala-Muniz, Puerto RicoSP-10.14Oncologic Outcomes and Predictive Factors for Progression in pT3 Renal Cell CarcinomaMeftun Culpan, TurkeySP-10.17Progression of Category 2F Bosniak Renal CystsMadhangi Parameswran, United KingdomSP-10.18Radiomic Features from Perinephric Fat May Aid Prediction of Histologic Grade in Clear Cell Renal Cell CarcinomaKevin Gerard Byrnes, IrelandSP-10.19Renal Cryoablation (RCA): Can It Hold a Place in the Treatment of Kidney Tumors?Luísa Jerónimo Alves, PortugalSP-10.20Risk Factors for Intravesical Recurrence After Nephroureterectomy for Upper Tract Urothelial CarcinomaSkander Zouari, TunisiaSP-10.24Trends of First-Line Targeted Therapy in Korean Patients with Metastatic Clear Cell Renal Cell Carcinoma: Sunitinib Versus Pazopanib, a Multicenter StudyTeak Jun Shin, South KoreaSP-10.25Tumor Seeding and Recurrence After Laparoscopic vs Open Nephro-Ureterectomy for Transitional Cell Carcinoma of Upper Urinary Tract (UUT)Andrea Liaci, ItalySP-10.26Tumour Complexity Does Not Affect the Ability to Achieve Trifecta Outcomes in Patients Undergoing Partial Nephrectomy for Kidney CancerJohn El-Khoury, AustraliaSP-10.27Voiding Dysfunction after Distal Ureterectomy in Patients with Upper Urinary Tract Urothelical CarcinomaYoshitsugu Nasu, JapanMinimally Invasive Surgery/Robotics SP-11.01Angiography of the Neurovascular Bundle Using Indocyanine Green and Near-Infrared Fluorescence: A Simple, Non-Invasive Technique for Nerve-Sparing Procedures During Robot-Assisted Radical ProstatectomyNordine Amara, FranceSP-11.03First Robotic Adrenalectomy in Australia Using SOLOASSIST 2: A Perfectly Still CameraMatthew Farag, AustraliaSP-11.04Impact of Inflammatory Bowel Disease on Radical Prostatectomy Outcomes and Costs of CareIlana Goldberg, United StatesSP-11.05Impact of Surgical Wait Times During Summer Months on The Oncological Outcomes Following Robotic-Assisted Radical Prostatectomy: 10 Years’ Experience from A Large Canadian Academic CenterAhmed S. Zakaria, CanadaSP-11.06Intra-Operative Bladder Neck and Urethral Dimensions During Robotic-Assisted Radical Prostatectomy (RARP) Are Associated With 3- and 6-Month Continence OutcomesJo-Lynn Tan, AustraliaSP-11.07Laparoscopic Simple Enucleation of Renal TumorTania Goznález León, CubaSP-11.08Laparoscopic Surgery of HydronephrosisSuniyat Kussymzhanov, KazakhstanSP-11.10Lymph Node Yield in Radical Cystectomy- Is a Minimally Invasive Approach Equivalent to Open Surgery?Praanjal Gupta, IndiaSP-11.11Management of Major Complication After Robot-Assisted Laparoscopic Partial NephrectomyMuhammed Fatih Simsekoglu, TurkeySP-11.12Maximization of Membranous Urethral Length During Robot-Assisted Radical Prostatectomy Increases Climacturia RecoveryFarouk El-Khatib, United StatesSP-11.13Membranous Urethral Length (MUL) as a Predictor of Continence in Post Transurethral Resection of Prostate (TURP) Patients Undergoing Robotic Assisted Radical Prostatectomy (RARP)Samuel Folkard, United KingdomSP-11.14Open Conversion in Lumboscopic Urological SurgeryTania González-León, CubaSP-11.15Prediction of Recovery Time of Urinary Incontinence After Robot-Assisted Laparoscopic Radical ProstatectomyKosuke Kitamura, JapanSP-11.17Reporting Quality of Randomized-Controlled Trials in Urological Robotic Versus Laparoscopic Surgery: A Systematic ReviewAlexander Light, United KingdomSP-11.20Robot-Assisted Ureteral Re-Implantation: A Single Centre Experience of 10 YearsZeeshan Kareem, IndiaSP-11.21Robot-Assisted Ureterolithotomy: An Additional Option for Large and Impacted UreterolithiasisWei-Shiang Hu, TaiwanSP-11.22Single-Port vs. Multi-Port Robotic Radical Prostatectomy: 100 vs. 110 Consecutive Cases in a Single Center Comparative StudyLouis Lenfant, United StatesSP-11.26The Impact of a Live Bedside Video Stream During Robot-Assisted Surgery on InterruptionsUmar Iqbal, United StatesSP-11.27The UroLift Implant Mechanism of Action for Relief from Prostatic ObstructionMark Rochester, United KingdomSP-11.29Utilising the Robot Video to Locate Misplaced NeedlesXuan Rui Sean Ong, AustraliaMiscellaneous SP-12.01125 Days of COVID-19 Pandemic: Virtual Office Urology Care TransformationEmmanuel Abara, CanadaSP-12.02A Multi-Centre Study Comparing Acute Urological Admissions During COVID-19 Lockdown to a Pre-COVID PeriodNyemahame Okwu, United KingdomSP-12.03A Systematic Review and Meta-Synthesis of the Effect of Prostate Cancer on Men’s Body Image, Self-Esteem, and Sense of MasculinityJessica Bowie, United KingdomSP-12.04A Systematic Review of Tools Used in Men with Prostate Cancer to Assess Body Image, Masculinity and Self-EsteemJessica Bowie, United KingdomSP-12.05Alfa - Blockers only the Choice for Indwelling Ureteral Stent Related Symptoms? A Randomized Prospective Clinical StudyNitin Pingale, IndiaSP-12.07An Audit on Indications for Flexible Cystoscopy and Outcome of Red Patch BiopsyAswathy Pavithran, United KingdomSP-12.08Anxiety, Depression and Suicidality in Prostate Cancer: A Systematic Review and Meta-AnalysisOliver Brunckhorst, United KingdomSP-12.10Audit of Haematuria Referrals: Is a Diagnostic Flexible Cystoscopy Mandatory in Young Adults (aged 15-49) in the COVID Era?Fawad Arif, United KingdomSP-12.12Decline in Urological Referrals During Covid-19 PandemicNuno Dias, PortugalSP-12.13Efficiency of Radiology Image Examination in Multidisciplinary Meetings – Technology Failures Delay Management DecisionsDominic Bagguley, AustraliaSP-12.14E-Visits: Transforming Doctors’ Office Visits in Time and SpaceEmmanuel Abara, CanadaSP-12.15Exploring Urologists Participation in Oncology Care Model and Bladder Cancer Related UtilizationZafardjan Dalimov, United StatesSP-12.16Falling Short in a Polypharmacy Era. Suspension of Post-TURP MedicationKelvin Adasonla, United KingdomSP-12.17High Dose Preoperative Gentamicin for Urologic Surgery and Risk of NephrotoxicityJane T. Kurtzman, United StatesSP-12.18How Much Is Preventative Counseling Effective in Those Patients Who Underwent Stone Surgery? A Study from Developing CountryAisha Hasan, PakistanSP-12.19Impact of Mental Well-Being in Urological Cancer: A Systematic ReviewAyushi Anna Dinesh, United KingdomSP-12.20Impact of the COVID-19 Pandemic on Daily Urology Practice: First 3 Months Multicenter Results in IstanbulAyberk Iplikci, TurkeySP-12.21Initial Experience of Tracking Ureteric Stents and Symptoms Using “UROSTENTZ” Smartphone Application: A Prospective, Single Centre Study of 100 Days and 100 Patients (eS.T.A.M.P TRIAL: Stent Tracking And Monitoring Patient Symptoms )Milap Shah, IndiaSP-12.22Knowledge and Radiation Safety Practices in Urology Theatres: A Collaborative Multi-Centre SurveyKelly Ong, United KingdomSP-12.23Management of 6Fr Polymer Ureteral Stent Failure in the Setting of Malignant Ureteral ObstructionHan-Kuang (James) Chen, AustraliaSP-12.24Management of Hydronephrosis in Patients with Advanced Tumours. a Challenge for UrologistsAlberto del Cristo Artiles Medina, SpainSP-12.25Mobile Application for Appropriate Needle Size Calculation During Laparoscopic SurgeryKostas Chondros, GreeceSP-12.27Oncology Care Model and Urologists: Prospects for Prostate Cancer CareZafardjan Dalimov, United StatesSP-12.28Optimal Use of CT KUB: Review of Patients Presenting with Acute Flank Pain in a Tertiary Care HospitalNaveed Haroon, PakistanSP-12.29Outcomes Following Prehabilitation for Urological Cancer Surgery: A Systematic Review and Meta-Analysis of Randomized-Controlled TrialsAlexander Light, United KingdomSP-12.30Patient Satisfaction with Teleurology Virtual ConsultationNimlan Shanmugathas, United KingdomSP-12.31Proportion of Publications Authored by Editors is Associated with Journal Blinding ChoiceJames Flanary, United StatesSP-12.32Revolutionising Urology Outpatient Appointments in the COVID-19 Era: Are Telephone Consultations Safe?Alexandra Guy, United KingdomSP-12.33Satisfaction Rates of Inflatable Penile Prostheses in Men Who Have Sex with MenJustin La, United StatesSP-12.34The 100 Most Influential Studies in Prostate Cancer Research: A Bibliometric AnalysisAlexander Light, United KingdomSP-12.36The Variability of the 12th Rib as a Landmark for SurgeryJake Tempo, AustraliaSP-12.37Urological Complications following Total Pelvic Exenteration – A Single Institution Experience with 5 Year Follow upKarthik Rajan, United KingdomSP-12.38Urologist Satisfaction with Virtual ConsultationChristopher C. Khoo, United KingdomSP-12.39Urology Telehealth in Regional Australia: Investigating Patient Perceptions of a Rising TechnologyJonathan O'Brien, AustraliaSP-12.40Use of Cannabis in Urological Cancer Patients: A Systematic Review of Risk for Cancer Development and Symptom ManagementShipra Taneja, CanadaSP-12.41Validation of a Modified Infrapubic Incision for Bilateral Total Orchidectomy in Management of Advanced Prostate Cancer in an African PopulationRotimi David, NigeriaPediatric UrologySP-13.02Combined Interferential Electrical Stimulation and Pelvic Floor Muscle Exercises for Treatment of Giggle Incontinence in ChildrenLida Sharifi-Rad, IranSP-13.05Evolution of the Low Mid Scrotal Incision (LMSI) in Cases of Undescended Testis (UDT): Single Surgeon's 15-Year Experience in KenyaSafwat Andrawes, KenyaSP-13.06Individualized Treatment of Bladder/Prostate Rhabdomyosarcoma (B/P RMS) with a Monotherapy Treatment ApproachAhmed Atwa, EgyptSP-13.07Mainz Pouch II (MP II) For Bladder Exstrophy (BE),?18 Years’ ExperienceSafwat Andrawes, KenyaSP-13.08Outcomes of Continent Catheterizable Channel – Children CohortNadeem Iqbal, PakistanSP-13.10Role of Ureterocalicostomy in Management of Giant Hydronephrosis in Children in Contemporary Practice: Indications, Outcomes and ChallengesNayab Danish, IndiaSP-13.11The Clinicopathologic Behavior of Wilms Tumor in KenyaTimothy Jumbi, KenyaPenis/Testis/Urethra: Cancer SP-14.01Expression of Programmed Death Ligand-1 (PD-L1) in Metastatic and Post-Chemotherapy Viable Testicular Germ Cell TumorsPaul Toren, CanadaSP-14.02Anxiety, Depression and Quality of Life Patient-Reported Outcome Measures in Testicular Cancer: A Systematic ReviewAmine Nur Dincer, United KingdomSP-14.03How Informative Are YouTube Videos on Testicular Cancer?Nuno Dias, PortugalSP-14.04Optimal Surgical Margin for Penile Sparing Surgery in Management of Penile Cancer - Is 2 cm Really Necessary?Elliot Anderson, AustraliaSP-14.05Testicular Lymphoma: What the Urologist Needs to KnowAlberto del Cristo Artiles Medina, SpainSP-14.06Urethroplasty for Urethral Stricture Disease and Its Association with Urethral Cancers: Case Report and Review of LiteratureAbdullah Al-Mitwalli, United KingdomPenis/Testis: Benign Disease SP-15.01A Review of Urethral Stricture Management and Guideline Conformity at a Tertiary Center in AustraliaAngela Holmes, AustraliaSP-15.02Disposable Circumcision Circular Stapler - Is It Really Time-Saving?Sónia Ramos, PortugalSP-15.03Long-Course Intralesional Collagenase in Peyronie's Disease Results in Objective and Patient Reported QOL Improvements Without Changes in Erectile FunctionAndreas Espehana, United KingdomSP-15.04Penile Calciphylaxis: A Conservative ApproachOmar El-Taji, United KingdomSP-15.05Penile Length Shortening Following Robot-Assisted Radical Prostatectomy: Impacts on Erections and Sexual BotherFarouk El-Khatib, United StatesSP-15.06Role of Neutrophil to Lymphocyte and Platelet to Lymphocite Ratios in Peyronie’s DiseaseEsther García Rojo, SpainSP-15.07Should We Treat Non-Clinical Varicoceles in Infertile Men with Normal Semenalysis but Raised DNA Fragmentation?Andreas Espehana, United KingdomSP-15.08Signalling Pathways and Genetic Supports of the Penile Fibrotic Disorder- Peyronie’s DiseaseNouha Bouayed Abdelmoula, TunisiaSP-15.09Treatment of Peyronie's Disease with Platelet Rich Plasma (PRP)Raouf Salti, SwitzerlandProstate CancerSP-16.02Different Pathological Types of Adult Prostate Sarcoma were Associated with Distinctive Prognosis: Experience of a High-Volume Center in ChinaRui Chen, ChinaSP-16.03Docetaxel Use Relative to Publication of Phase III Evidence: A National Analysis of Prescribing Trends in AustraliaArsalan Tariq, AustraliaSP-16.04Duration of Androgen Deprivation Therapy Significantly Impacts Development of Osteoporosis in Japanese Patients with Prostate CancerKanade Hagiwara, JapanSP-16.05Evaluation of the Clinical and Cost Effectiveness of Routine Pre-Op Group and Screen Samples and Routine Post-Op Bloods for Robotic Assisted Radical Prostatectomy (RARP)Yuzhi Phuah, United KingdomSP-16.08Re-Defining Optimal Testosterone Castration Level when Assessed by Mass Spectrometry in Castration-Sensitive Prostate Cancer PatientsJérémie Beck, CanadaSP-16.11The Uro-Oncology Multi-disciplinary Team (MDT) Clinic – Clinical and Patient Reported Outcomes from Implementing a New Model of CareRaj Tiwari, SingaporeSP-16.12Urological Outcomes in Nonagenarians with Prostate CancerHeather Morris, CanadaSP-16.14Comparing the Convergent and Discriminant Validity of Three Quality of Life Measures Following Treatment for Prostate CancerNorma B. Bulamu, AustraliaSP-16.15E2F1 Reduces DNA Damage Repair Through ATM-CHK2-FOXO3a Axis and Enhances Radiosensitivity of Prostate CancerHai Huang, ChinaSP-16.16MicroRNAs as Potential Liquid Biopsy Biomarkers in Patients Who Progressed to Castration Resistant Prostate CancerJulian Chavarriaga, ColombiaSP-16.18Prostate Cancer Cells Promoting Tumor Progression through T Cell Receptor NRP1Fei Liu, ChinaSP-16.19PSAPP, the Smartphone Application for PSA Doubling Time and PSA DensityFederico Ferraris, ArgentinaSP-16.20Tissue Zinc Concentration in Prostate Cancer: Relationship with Prostate Specific Antigen and Gleason Score in a Cohort of Nigerian MenMartin Igbokwe, NigeriaSP-16.21A Look of Incidental Prostate Cancer Trend from Robotic-Assisted Simple Prostatectomy in Modern EraChe Hsueh Yang, TaiwanSP-16.22Active Surveillance for Prostate Cancer: Comparison of Initial Multi-Parametric MRI and TRUS Biopsy with Repeat ResultsAngus Bruce, United KingdomSP-16.23Affordable Device (VY-001) for Transperineal Prostate Biopsy: A Trial on Prostate MannequinYasser Kuddah, IndonesiaSP-16.25Can Paired Ga68 PSMA PET CT Scan and Multiparametric MRI Enable Better Diagnosis and Treatment of Biochemical Recurrence Post Radical Prostatectomy?Vidyasagar Chinni, AustraliaSP-16.26Characterisation of Prostate Lesions Using Transrectal Shear Wave Elastography (SWE) Ultrasound Imaging: A Systematic Review and Meta-AnalysisThineskrishna Anbarasan, United KingdomSP-16.27Clash of the Calculators: External Validation of Prostate Cancer Risk Calculators in Men Undergoing Magnetic Resonance Imaging and Transperineal BiopsyGavin Wei, AustraliaSP-16.29Comparing Tolerability of Local Anaesthetic Transperineal and Transrectal Prostate BiopsiesBenjamin Starmer, United KingdomSP-16.30Concomitant Anoscopy Can Control the Rectal Bleeding Following Transrectal Prostate BiopsyYoshitsugu Nasu, JapanSP-16.32Discriminant Efficacy of mpMRI for Variant Pathology Associated with Prostate AdenocarcinomaHikmet K?seo?lu, TurkeySP-16.35Evaluating the Diagnostic Role of In-Bore Magnetic Resonance Imaging Guided Prostate Biopsy – A Prospective Single-Center StudyAnne Hong, AustraliaSP-16.37How Can We Better Stratify Patients Needing PSMA PET Scan for Early Detection of Prostate Cancer Recurrence after Robotic ProstatectomyKetan Agarwal, United KingdomSP-16.38Improved Prostate Cancer Risk Assessment with Federal Funding for Magnetic Resonance Imaging of the Prostate: Australia Population DataGavin Wei, AustraliaSP-16.39Increased Infection Rates Following Single Dose Antibiotics for TRUS Guided Biopsy of the ProstateMatthew Farag, AustraliaSP-16.40Influence of Prior Atypical Small Acinar Proliferation in the Gleason Score in Subsequent Prostate BiopsyMarta Jiménez Navarro, SpainSP-16.41One-Year Experience of Government-Funded MRI Prior to Prostate Biopsy: A Case for Omitting Biopsy in Men with a Negative MRIJohn El-Khoury, AustraliaSP-16.42Outcomes of Incidentally Found Prostate Cancer After Radical CystoprostatectomyMriganka Mani Sinha, United KingdomSP-16.43Persistent Hematuria Following Prostate Biopsy: A Novel Method of Management and Review of LiteratureNarayanaswamy Arun, KuwaitSP-16.44PSA Density in the Diagnosis of Prostate Cancer in Chinese Population: Results from the Chinese Prostate Cancer ConsortiumRui Chen, ChinaSP-16.45Significance of Incidental Prostate Avidity on FDG PET/CTAnthony Franklin, AustraliaSP-16.46Subjective Pain Intensity and Type of Local Anesthesia: A Randomized Study on Transrectal Prostate BiopsyKostas Chondros, GreeceSP-16.47The Impact of Health Policy Subsidisation of Prostate Magnetic Resonance Imaging on Prostate Biopsy Practice Patterns and OutcomesGavin Wei, AustraliaSP-16.48The Predictive Value of Prostate Specific Antigen Density (PSAD), Percentage Free Prostate Specific Antigen (%fPSA) and The Combination (PSAD+%fPSA) For Prostate Cancer Detection in The Grey ZoneFelix Echebiri Magnus, NigeriaSP-16.50The Risk of Missing Clinically Significant Prostate Cancer in Men with Anterior Prostate Lesions on Multiparametric Magnetic Resonance Imaging (mpMRI)Jane T. Kurtzman, United StatesSP-16.51The Role of Single-Dose Fosfomycin as Alternative Prophylaxis in Patients Undergoing Transrectal Ultrasound-Guided Biopsy of The Prostate: A Meta-Analysis of Randomized Controlled TrialNiwanda Yogiswara, IndonesiaSP-16.55Usefulness of Prostate Specific Antigen Density in Prostate Cancer Detection Among Africans with Intermediate Prostate Specific Antigen (4.0-10.0 ng/mL)Christian Agbo, NigeriaSP-16.56Utilising Pre-Biopsy Prostate mpMRI to Predict Gleason Score Change at Radical ProstatectomyAnthony Franklin, AustraliaSP-16.57Will Adding Routine Systematic Biopsy to Targeted Multiparametric MRI-Ultrasound Fusion Prostate Biopsy Improve the Detection of Prostate Cancer?Ralph Albert Patrick Uy, PhilippinesSP-16.60Active Surveillance for Prostate Cancer: Identifying the Most Appropriate Time for Conducting Confirmatory Biopsies and Evaluating the Role of MRI Scan - A Retrospective StudyAshwini Gaur, United KingdomSP-16.61Anterior Prostate Fat Resection During Prostatectomy: A Histopathologic ReviewAlexandra Guy, United KingdomSP-16.62Can Histo-Pathological Tumor Contact Length Percentage Be an Important Prognostic Marker for Biochemical Recurrence Following Radical Prostatectomy for Pathological T2 Stage Prostate Cancer with Negative Surgical Margin?Rohan Sharma, IndiaSP-16.63Can Transurethral Resection of the Prostate Become Another Gateway to the Focal Therapy for Localized Prostate Cancer?Takeshi Matsuura, JapanSP-16.66Comparison of Management Strategies for Low-Risk Prostate Cancer Patients: Early Oncological and Functional Outcomes, and The Impact of Prior MRI in Patient SelectionAlberto del Cristo Artiles Medina, SpainSP-16.67Data from the Prostate Cancer Outcomes Registry of Australia and New Zealand (PCOR-ANZ): Population Level Patterns of Care and Patient-Reported OutcomesMichael O'Callaghan, AustraliaSP-16.69Experience with Robotic Assisted Radical Prostatectomy and Extended Lymphadenectomy for Prostate CancerKermith Ayala-Muniz, Puerto RicoSP-16.71Focal Low Dose Rate Brachytherapy for Unifocal Low Intermediate Prostate Cancer - Preliminary ExperienceElliot Anderson, AustraliaSP-16.72Impact of Mental Well-Being in Prostate Cancer Patients Undergoing Active SurveillanceAyushi Anna Dinesh, United KingdomSP-16.74Management and Survival of Prostate Cancer in Kidney Graft RecipientsPablo Abad-López, SpainSP-16.75Neoadjuvant Androgen Deprivation Therapy Before Prostatectomy: Will History Repeat Itself?Xuan Rui Ong, AustraliaSP-16.76Outcomes of Magnetic Resonance Imaging-Based Active Surveillance for Prostate Cancer: Predictors of Upgrading in Confirmatory Biopsy and Surgical SpecimenSilvia García Barreras, SpainSP-16.78Radical Prostatectomy or Low Dose Rate (LDR) Seed Brachytherapy; Is There Any Difference in PSA Relapse Free Survival with Long-Term Follow-Up, A Matched Pair AnalysisDanielle Clyde, United KingdomSP-16.80Relationship Between Biochemical Recurrence and PSA Nadir in Prostate Cancer Patients Treated with Iodine-125 BrachytherapyPablo Francisco Martinez, ArgentinaSP-16.82Robot Assisted Radical Prostatectomy Performed at Ultra-Low Insufflation Pressure (6mmHg): Is it Safe Compared to Standard Practice?Gaurav Sharma, United KingdomSP-16.83Survival Outcomes in Men with a Positive Family History of Prostate Cancer: A Registry Based StudyMichael O'Callaghan, AustraliaSP-16.85Understaging on Prostate Biopsy and its Impact on Biochemical RecurrenceMarta Jiménez Navarro, SpainSP-16.86Where the Nerves Meet the Margins: A Longitudinal Long-Term Single Center Study Exploring the Feasibility of Nerve Sparing Radical Prostatectomy in High-Risk Prostate Cancer PatientsJonathan O'Brien, AustraliaSP-16.87Will Delays in From the Coronavirus Pandemic Affect Localised Prostate Cancer Outcomes?Xuan Rui Ong, AustraliaSP-16.88A Preliminary Descriptive Analysis of the Quality of Life from Men at Risk of Prostate CancerRoxane Tourigny, CanadaSP-16.9068Ga-PSMA PET/CT Accurately Predicts Disease Stage in Men with Radiation Failure Undergoing Salvage Radical ProstatectomyDominic Bagguley, AustraliaSP-16.9168Ga-PSMA PET/CT for Prostate Cancer: 2 Years’ Experience in a Secondary Referral CentreKarel Dewulf, BelgiumSP-16.92Cribriform Formations as an Indication of Gleason Upgrading in Comparison of Prostate Cancer SpecimensAleksandar Ilievski, North MacedoniaSP-16.93Determining Predictive Factors of Upgrading and Upstaging in Low-Risk Prostate Cancer Patients Treated with Radical ProstatectomyAlberto del Cristo Artiles Medina, SpainSP-16.94Diagnostic Utility, Location of PSMA Avid Lesions and Sensitivity and Specificity of 68Ga-PSMA PET in Biochemically Recurrent Prostate Cancer: An Updated Systematic Review and Meta-AnalysisMarlon Perera, AustraliaSP-16.95Impact of MRI and Targeted Biopsies on Prostate Cancer Reclassification in Men on Active Surveillance in the Confirmatory Biopsy SettingSilvia García Barreras, SpainSP-16.97Low MRI-Based Prostate-Specific Antigen Density Predicts Clinically Insignificant Prostate Cancer in Active Surveillance Cohort with Negative Magnetic Resonance ImagingSilvia García Barreras, SpainSP-16.98Organ Confined Gleason 4+3 Prostate Cancer with PSA Less Than 20. Is the Bone Scan Necessary?Ashwini Gaur, United KingdomSP-16.99PET/CT Radiomic Analysis Performed Preoperatively to Predict Lymph Node Metastases at Radical Prostatectomy for High-Grade Prostate CancersDanahé LeBlanc, CanadaSP-16.100Positive Surgical Margins After Radical Prostatectomy: Can Gleason Grade Group of Margin Help Determine Risk of Biochemical Recurrence? - A Systematic Review and Meta-AnalysisAthul John, AustraliaSP-16.101Role of Dual Reporting of MRI in Diagnosing Prostate CancerVidyasagar Chinni, AustraliaReconstructionSP-17.01A Novel Buccal Tissue Transportation and 3D Cell Culture System Using a Polymer Scaffold for Cell Therapy Application in Urethral StrictureSamuel JK Abraham, JapanSP-17.02A Population-based Analysis of Iatrogenic Ureteral Injury in South KoreaByeong Jo Jeon, South KoreaSP-17.03Adequacy of Retrograde Urethrograms in Surgical Decision Making for Anterior Urethral Strictures: A Prospective StudyRowan David, AustraliaSP-17.04Anastomotic Stricture Repairs in Transgender Men Post-PhalloplastyDmitriy Nikolavsky, United StatesSP-17.05Assessment of Long-Term Outcome, Complications, and Impact on Renal Function in Bladder Reconstruction with Ileal Segments: Review from a Tertiary Center in Western IndiaAbheesh Varma Hegde, IndiaSP-17.06Autologous Dermal Graft in the Treatment of Penile DysmorphophobiaBorko Stojanovic, SerbiaSP-17.07Comparative Study of Clinical Outcome of Dorsal Buccal Mucosal Graft Urethroplasty by Onlay and Inlay Method for Stricture Involving Anterior Urethra in MenNitin Pingale, IndiaSP-17.08Disorder of Sexual Development (DSD) Management - 30 Years Experience of a Single Tertiary Care Centre in North IndiaRavi Banthia, IndiaSP-17.11Evaluating the Utility of Next Generation DNA Sequencing in Detecting Microorganisms in Explanted Urologic ProstheticsErica Mann, United StatesSP-17.12Experience with Single-Staged Urethroplasty for Anterior Urethral Reconstruction in Sub-Saharan AfricaRotimi David, NigeriaSP-17.13Fistulae after Prostate and Rectal Cancer Treatment – Similar but DifferentSimon Bugeja, United KingdomSP-17.15Implantation of an Artificial Urinary Sphincter (AUS) in Patients with Bladder Neck Contracture (BNC) or Prostatic Stenosis (PS) Managed Endoscopically. Is it Safe?Simon Bugeja, United KingdomSP-17.16Incidence of Erectile Dysfunction after Bulbar Urethroplasty: Assessment on Clinical History Compared with Standardised Questionnaire (SHIM)Nicola Jeffery, United KingdomSP-17.17Incidence of Post-micturition Dribble after Bulbar Urethroplasty using Transecting and Non-transecting ApproachesNicola Jeffery, United KingdomSP-17.18Long Term Oral Sodium Bicarbonate Supplementations. Role in Minimising Metabolic Acidosis in Long Term Ileocystoplasty Follow Up?Matthew Oxenham, United KingdomSP-17.20Low Rate of Urethral Stricture after Removal of Artificial Urinary Sphincter for Urethral Erosion, when Managed with Catheter AloneAnastasia Frost, United KingdomSP-17.21Maintaining Urethral Voiding in Elderly, Frail Patients: Off-Label Use of the Epic Vascular Self-Expanding StentShawn Mendonca, United StatesSP-17.22Management of Neurogenic Stress Urinary Incontinence in Spinal Cord Injured Patients with the Remeex ? Adjustable Synthetic SlingRodrigo Andres Campos, ChileSP-17.23Modified Non-Dismembered Hydronephrosis Plastic in Ureteropelvic Junction (UPJ) ObstructionVolodymyr Chernylovskyi, UkraineSP-17.24Open Pyeloplasty Versus Laparoscopic Pyeloplasty for Primary Pelvi-Ureteric Junction Obstruction: A Single Centre Prospective StudyOmer Farooq Rehman, PakistanSP-17.25Outcomes of Inner Preputial Graft (IPG) Urethroplasty-Our Experience from a Tertiary Care Centre!Kalpesh Parmar, IndiaSP-17.26Penile Skin Flap Urethroplasty for the Patients with Urethral Stricture Unfit for Buccal Mucosa Graft: A Modification of Surgical Technique and Preliminary ResultsYozo Mitsui, JapanSP-17.27Postoperative Oral Pain Following Buccal Mucosal Graft Urethroplasty is Related to Oral Graft Site Wound ClosureJane T. Kurtzman, United StatesSP-17.30Routine Retrograde Urethrogram to Detect Recurrence of Idiopathic Bulbar Urethral Stricture After Urethral Dilatation in a Contemporary CohortNicola Jeffery, United KingdomSP-17.31Successful Penile Replantation with Cavernosoglandular Shunt Procedure: A Case SeriesAndrian Rivanda, IndonesiaSP-17.32The Management of Patients with Urethral Strictures Due to Lichen SclerosusAnastasia Frost, United KingdomSP-17.34The Search for the Ideal Graft: A Histologic Comparison of Colonic and Buccal Mucosal GraftsShawn Mendonca, United StatesSP-17.35Trends in Inflatable Penile Prostheses Over TimeBridget Heijkoop, AustraliaRenal TransplantationSP-18.01Dual (En-Bloc) Renal Transplantation from a Pediatric Deceased Donor – A Technical AppraisalPraanjal Gupta, IndiaSP-18.02Experience and Early Outcomes of Kidney Transplantation in a Nigerian Transplant Institution: A 1-Year ReviewMartin Igbokwe, NigeriaSP-18.03Immunosupressive Treatment and Graft Survival in Kidney Transplant Recipients with Prostate CancerPablo Abad-López, SpainSP-18.05Systemic Vascular Function of Kidney Donor Influences Short-Term Renal Performance of ReceptorEsther García Rojo, SpainSP-18.06The Outcome Results of Live Related Renal Transplants With the Use of Ringer Lactate and Additives as a Cheaper Alternative to Organ Preserving Solutions in a Public Run Hospital in a Developing Country - Our Experience for the Past 5 YearsAbheesh Varma Hegde, IndiaSP-18.07Urological Malignancies in Kidney Transplanted Patients - 552 Patients Single Center ExperienceNuno Dias, PortugalSexual DysfunctionSP-19.01A Systematic Review and Meta-Analysis of Erectile Function Post Prostate BiopsyArihant Mehta, United KingdomSP-19.03Climacturia After Robot Assisted Radical Prostatectomy: Does Pre-Operative Erectile Dysfunction Affect Who Recovers?Farouk El-Khatib, United StatesSP-19.04Does Patient- and Partner- Perceived Penile Shortening Post-Radical Prostatectomy Independently Impact Sexual Function Recovery?Linda Huynh, United StatesSP-19.05Erectile Function Following Surgery for Benign Prostatic Hyperplasia: A Systematic Review and Network Meta-Analysis of Randomized-Controlled TrialsAlexander Light, United KingdomSP-19.07Immediate Post-Operative PDE5i Therapy Improves Early Erectile Function Outcomes after Robot-Assisted Radical Prostatectomy (RARP)Amil Sinha, United KingdomSP-19.09Platelet-Rich Plasma Injections for Erectile Dysfunction and Peyronie’s Disease: A Systematic Review of EvidenceNawar Touma, CanadaSP-19.10Predictive Ability of Free Testosterone on Sexual Function in Prostate CancerEdward Choi, United StatesSP-19.13Spinal Cord Injury Patients Have a Higher Risk of Postoperative Complications After an Inflatable Penile Prosthesis ImplantationLaura Velarde Ramos, ChileStonesSP-20.02Avoid the Opioid! An Australian Intervention Study to Improve Analgesia Choice for Acute Renal ColicLiang Qu, AustraliaSP-20.03Efficacy of Extracorporeal Shock Wave Lithotripsy Performed under General Anesthesia General Anesthesia for Hard Renal Stones: A Single Centre StudyVenkates Thuraiyur Kamaraj, IndiaSP-20.05Emergency Ueteroscopy Service Reduces Patient Morbidity and Need for Secondary Procedures in Acute Stone PatientsCherrie Ho, United KingdomSP-20.07Laser Lithotripsy: Settings for SurgeonsMatthew Farag, AustraliaSP-20.09Novel Predictive Nomogram for Predicting Ureteral Stone PassageNassib Abou Heidar, LebanonSP-20.10Outcomes and Predictors of Change in Renal Function After Percutaneous Nephrolithotomy in Patients of Renal Stones with Chronic Kidney DiseaseAditya Sharma, IndiaSP-20.11Risk of Bounceback Requiring Decompression in Patients with Obstructive Urolithiasis Managed with Trial of PassageEzra Margolin, United StatesSP-20.12The Role of CT Thorax in Patients Presenting with Suspected Obstructive Urolithiasis during the COVID-19 PandemicThomas Thompson, United KingdomSP-20.13Trends in Alpha-Blocker Usage for Ureteral Stones: How Has Evidence Impacted Practice in Australia?Liang Qu, AustraliaSP-20.14Anaesthetic Free Extracorporeal Shock-Wave Lithotripsy for Ureteric Calculi in the Acute Setting: Initial Experience and Outcomes in an Australian CentreJohn El-Khoury, AustraliaSP-20.15Changing Etiology, Treatment and Outcomes of Urethral Calculi in the 21st Century: A Systematic ReviewArsalan Tariq, AustraliaSP-20.17Comparative Analysis of Mini Percutaneous and Standard Percutaneous Nephrolithotomy (PCNL) in the Treatment of Renal StonesAlberto del Cristo Artiles Medina, SpainSP-20.18Comparison Between Single Step and Multistep Dilatation in PCNL – Experience from a Tertiary Centre in a Developing CountryAbheesh Varma Hegde, IndiaSP-20.19Does Surgeon Experience and Stone Size Predict Radiation Exposure in Emergency Ureteric Stent Insertion?Gemma Scrimgeour, United KingdomSP-20.21Evaluation of Flexible Ureteroscopy Complications in a Spanish CohortEduardo García Rico, SpainSP-20.22Has the SARS-CoV-2 Pandemic Improved the Management of Acute Ureteric Colic?Nimlan Shanmugathas, United KingdomSP-20.23Initial Experience of Miniaturised PCNL with Swiss LithoClast? Trilogy: A European Multicentre Prospective Study on Behalf of ESUTNiyukta Thakare, United KingdomSP-20.24Initial Human Experience with Slimmest Single-Use Flexible Ureteroscope Uscope PU3033A (PUSEN?) in Retrograde Intrarenal Surgery and Its Comparison with Uscope PU3022a: A Single Center Prospective StudyShashank Agrawal, IndiaSP-20.25Is Successful Stone Management Truly Achievable in the Emergency Setting?Anil Krishan, United KingdomSP-20.26Mini Percutaneous Nephrolithotomy: A Viable Single Stage Treatment for Pediatric NephrolithiasisOmer Farooq Rehman, PakistanSP-20.27Outcome of PCNL in Old Age Patient-Single Centre ExperienceShehnaz Ashiq, PakistanSP-20.29Pediatric Renal and Ureteric Stones. A Single-Centre Study from Third World CountryNadeem Iqbal, PakistanSP-20.31Prediction of Success Rate of Shock Wave Lithotripsy Using Mean Stone Density, Stone Heterogeneity Index and Mean Stone Density-Stone Heterogeneity Index Ratio in Different Sizes of Upper Tract StonesAisha Hasan, PakistanSP-20.32Role of Peri-Calculus Ureteral Thickness on CT Scan to Predict Stone Impaction at Time of Surgery. A Single-Center AnalysisNadeem Iqbal, PakistanSP-20.34Study of Factors Predicting Impacted Nature of Ureteric Stones in Patients Undergoing Ureteroscopic Lithotripsy (URSL)Suraj Pinni, IndiaSP-20.35Supine versus Prone PCNL in the High Spinal Cord Injury PatientBridget Heijkoop, AustraliaSP-20.36Surgical and Radiological Predictive Factors for Ureteric Stricture Formation After Ureteroscopic Treatment of Impacted Ureteric StonesZuhdi Al-Nabulsi, United KingdomSP-20.37The Efficacy and Safety of the EMS Swiss LithoClast? Trilogy for PCNL: Results of the First European Multicentre Prospective Study on Behalf of ESUTNiyukta Thakare, United KingdomSP-20.39The Required Case Number to Achieve Financial Sustainability for Percutaneous Nephrolithotomy (PCNL) in the United KingdomCherrrie Ho, United KingdomSP-20.40To Assess the Complications Rate of Conventional Percutaneous Nephrolithotomy (PCNL) in a Tertiary Care CenterMuhammad Asif, PakistanSP-20.41Ultrasound Guided Percutaneous Ureterolithotripsy versus Semi-Rigid Ureterolithotripsy for Impacted Upper Ureteric Calculi – A Randomized Control TrialOmer Farooq Rehman, PakistanSP-20.42Ureteral Wall Thickness Affect the Success of Ureteroscopy Treatment in Ureteral Stones above the Iliac CrossEmre Bulbul, TurkeySP-20.43Ureterenoscopy in an Australian Tertiary Centre: Costing Individual StonesRomy Mondschein, AustraliaSP-20.44Ureteric Stents with Extraction Strings - A Safe PracticeNaresh Kumar Kaul, IndiaSP-20.45Utility of Post-Fragmentation Cultivation in the Management of Infectious Complications after Endoscopic Treatment of Lithiasis.Lorena García García, SpainSP-20.46What Is the Best Way to Manage Ureteric Stones During COVID-19? A Comparison of Extracorporeal Shockwave Lithotripsy (ESWL) and Ureteroscopy (URS) in an Australian Healthcare SettingMatthew Farag, AustraliaSP-20.47Intrarenal Pressure Stability at Different Lithotripter Suction Settings in a Kidney ModelMarkus Juergen Bader, GermanyTraining and EducationSP-21.01A Mixed Methods Approach for Practice Mapping Exercise and the Assessment of the Impact of Online Educational Intervention for the AUA 2020 Guidelines for Surgical Management of BPHDivakar Dalela, IndiaSP-21.02Acute Urological Emergencies in Leicester Medical School Undergraduate CurriculumAnton Wong, United KingdomSP-21.03An Evaluation of Education Regarding Urethral Catheterisation Technique in Australian Medical Schools - Before and After Targeted Educational InterventionsVaisnavi Thirugnanasundralingam, AustraliaSP-21.05Development and Evaluation of a Smartphone Light Adaptor for Bedside CystoscopyJen Hoogenes, CanadaSP-21.06Enhancing Singapore Urology Residents’ Training with Cross-Cluster Videoconferencing: A Pilot StudyRaj Vikesh Tiwari, SingaporeSP-21.07Impact of COVID-19 on Prospective Urology ApplicantsKate Hanson, United StatesSP-21.08Rapid Impact of the Virtual Skill Enhancement Program Across Asia and Africa to Address the Knowledge Gaps for the Utilisation of Urodynamics in Real World SettingAli Poonawala, IndiaSP-21.09SoMe and the PCP: Exploring the Role for Twitter to Educate Primary Care PractitionersJonathan O'Brien, AustraliaSP-21.10The Effect of COVID-19 on Urological Surgery Services and Training to the Peak of the Pandemic in South East EnglandSamuel Folkard, United KingdomSP-21.11Training Impact of Covid-19 for Urological and other Surgical Registrars in Three New Zealand Centres.Magnus Cheesman, New ZealandSP-21.12Urological Emergencies in a Nigerian Teaching Hospital: Epidemiology and TreatmentChike John Okeke, NigeriaSP-21.13Urological Surgery in a Nigerian Referral Hospital: How Long do We Wait?Chike John Okeke, NigeriaSP-21.14Use of YouTube as a Resource for Surgical Education: Clarity or Confusion?Matthew Farag, AustraliaTraumaSP-22.02Occupation Related Traumatic Urologic Injuries: A National Trauma Data Bank AnalysisShawn Mendonca, United StatesSP-22.03Sonographic and Exploration Findings in Patients with Testicular TraumaNuno Dias, PortugalSP-22.04Treatment of Penile Amputation Injury - Our ExperienceBorko Stojanovic, SerbiaVoiding DysfunctionSP-23.01Can Pre-Operative Transperineal Ultrasound (TPUS) Findings Predict Continence Outcome After Radical Prostatectomy?Vidyasagar Chinni, AustraliaSP-23.02Climacturia and Timing of Incontinence Recovery Post-Radical ProstatectomyEdward Choi, United StatesSP-23.03Efficacy of Fesoterodine Fumarate in Neurogenic Detrusor Overactivity (NDO) Due to Spinal Cord Lesion (SCL) or Multiple Sclerosis (MS) – A Prospective StudyCharalampos Konstantinidis, GreeceSP-23.04Evaluation of Detrusor Overactivity Indicators: A Single Center Experience from 2015-2020Ario Baskoro, IndonesiaSP-23.05Inflammatory Cytokines/Chemokines and Bacterial Loads Correlate with Voiding Behaviors in a Murine Urinary Tract Infection ModelKejia Zhu, ChinaSP-23.07Overactive Bladder Syndrome is Associated with Elevated Urinary proNGF to NGF Ratio in an Aging Female PopulationAbubakr Mossa, CanadaSP-23.08Potential Predicting Factors of Detrusor Underactivity: A Single Centre Experience From 2015-2020Soefiannagoya Soedarman, IndonesiaSP-23.09The Inpatient ‘Trial of Void’, Current Literature and Ways Towards Improvement: A Systematic ReviewVaisnavi Thirugnanasundralingam, AustraliaSP-23.10Third Sacral Foramen Lead Implantation Analysis for Sacral Neuromodulation in Chinese PopulationHai Huang, ChinaSP-23.11Would Botulinum Toxin a Detrusor Injections Decrease the Incidence of Symptomatic Urinary Tract Infections in Patients with Neurogenic Detrusor Overactivity?Mai Banakhar, Saudi ArabiaVideo ePosterAdrenalsVP-01.01Laparoscopic Management of Ectopic PheochromocytomaNasser Simforoush, IranBPO/LUTSVP-02.01Functional Outcomes of Extraperitoneal Laparoscopic AdenomectomyRoberto Martínez, SpainVP-02.02Long-Term Outcomes of Transurethral Enucleation and Resection of the Prostate for Benign Prostatic HyperplasiaPeng Xu, ChinaInfections and Inflammatory DiseasesVP-03.01Emergency Transurethral Deroofing of Bilateral Loculated Prostatic Abscesses in An Anticoagulated PatientJonty Bird, United KingdomInfertilityVP-04.01Microsurgical Vaso-epididymal Anastomosis- Comprehending the NuancesAditya Sharma, IndiaKidney and Ureter, Benign Diseases VP-05.01Concomitant Pelvic Ureteric Junction Obstruction with Retrocaval Ureter in Elderly Female: A Rare CombinationVaibhav Vishal, IndiaVP-05.02Total Ultrasound Guided Mini PCNLZeeshan Kareem, IndiaMinimally Invasive Surgery/Robotics VP-06.01A Case of Hutch Diverticulum Performed with Robotic-Assisted Diverticulectomy of Urinary BladderChe Hsueh Yang, TaiwanVP-06.02Bilateral Laparoscopic Ureteral Reimplantation in a Patient with Endometriosis: A Case PresentationRobab Maghsoudi, IranVP-06.03Endoscopic-Assisted Transvesical Laparoscopy (EtLap): A New Paradigm in Minimally-Invasive Bladder SurgeryYu Guang Tan, SingaporeVP-06.04Hem-O-Lok? Weck Clip Complications during Minimal invasive Urology Surgery and Tips & Tricks for its ManagementRohan, IndiaVP-06.05Modified Ileal Conduit Intracorporeally Accomplished Following Laparoscopic Radical CystectomyHouyi Wei, ChinaVP-06.06Modified Studer Orthotopic Neobladder Intracorporeally Performed Following Laparoscopic Radical CystectomyHouyi Wei, ChinaVP-06.07Robotic Cortical-Sparing Adrenal Surgery in Von Hippel Lindau (VHL): Treatment of Pheochromocytoma Metachronous Recurrence in a Patient with a Single Adrenal GlandSergio Guzman Karadima, ChileVP-06.08Robotic Nephron-Sparing Surgery in Complex Renal Tumor: A Standardized Technique, the Key to Success for an Inhospitable SettingMarcelo Kerkebe Lama, ChileVP-06.09Use of LEVITA Magnetic Surgical System to Improve Urological Surgery: Experience of a Single CenterSergio Guzman Karadima, ChileMiscellaneous VP-07.01Put the What, Where? Challenges to coordinating attention in Robot-Assisted Surgery: A Pilot StudyAntara Satchidanand, United StatesPediatric UrologyVP-08.01Megaprepuce Repair: The Anatomical ApproachWies Vanderbruggen, BelgiumProstate CancerVP-09.01Neoadjuvant Apalutamide Does Not Affect Robotic Prostatectomy OutcomesXinYan Yang, SingaporeVP-09.02Retzius-Sparing Laparoscopic Radical Prostatectomy - Is it Feasible without the Robot?Sónia Ramos, PortugalReconstructionVP-10.01Atoms Adjustable Sling: Could It Be Considered as an Effective Option for Complex Male Stress Incontinence Cases?Alvaro Saavedra, ChileVP-10.02Buccal Mucosa Endo-Laparoscopic Repair of Bladder Neck Stenosis after Radical ProstatectomyGunter De Win, BelgiumVP-10.03Laparoscopic Ureterovesical Reimplantation in Transplanted Kidney: Video PresentationNasser Simforoosh, IranVP-10.04Management of Urethrocutaneous Fistula – Innovative Use of Gracilis Muscle Flap around Buccal Mucosal Graft TubeSandesh Parab, IndiaVP-10.05Transanal Minimally Invasive Rectal Mucosal Graft Harvest for Staged UrethroplastyKarthik Tanneru, United StatesRenal TransplantationVP-11.01Single-Port Robotic Assisted Kidney Autotransplantation: Initial ExperienceLouis Lenfant, United StatesStonesVP-12.01Laparoscopic Treatment of Stones in Kidney with Anatomical Abnormality. Technique DescriptionM Teresa Melgarejo Segura, Spain ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download